{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:26:34Z","timestamp":1789989994496,"version":"4.0.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"TEVA"},{"name":"BiogenIdec"},{"DOI":"10.13039\/100006259","name":"TEVA Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck Serono"},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004702","name":"Baxter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000801","name":"Bayer Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BiogenIdec"},{"name":"Merck-Serono"},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008976","name":"Sanofi-Aventis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008976","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"TEVA Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Teva Pharma GmbH"},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006500","name":"Cure Huntington's Disease Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006314","name":"Biogen Idec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006314","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck Serono"},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008273","name":"Novartis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.expneurol.2016.08.012","type":"journal-article","created":{"date-parts":[[2016,9,4]],"date-time":"2016-09-04T17:52:06Z","timestamp":1473011526000},"page":"12-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"PA","title":["Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6\/2 and YAC128 mouse models of Huntington's disease"],"prefix":"10.1016","volume":"285","author":[{"given":"Christiane","family":"Reick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisa","family":"Ellrichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Saft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf A.","family":"Linker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2016.08.012_bb0005","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1038\/ncomms3917","article-title":"A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington's disease in mice","volume":"4","author":"Acuna","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0010","doi-asserted-by":"crossref","first-page":"10821","DOI":"10.1073\/pnas.94.20.10821","article-title":"Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis","volume":"94","author":"Aharoni","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0015","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1523\/JNEUROSCI.1859-05.2005","article-title":"Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis","volume":"25","author":"Aharoni","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0020","doi-asserted-by":"crossref","first-page":"19045","DOI":"10.1073\/pnas.0509438102","article-title":"The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice","volume":"102","author":"Aharoni","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0025","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1073\/pnas.0530191100","article-title":"Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis","volume":"100","author":"Angelov","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0030","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1002\/eji.200424883","article-title":"Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells","volume":"34","author":"Avidan","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00019052-200106000-00003","article-title":"Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences","volume":"14","author":"Bjartmar","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0040","doi-asserted-by":"crossref","first-page":"11784","DOI":"10.1073\/pnas.0604681103","article-title":"Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1","volume":"103","author":"Butovsky","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0045","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0050","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.bbagen.2013.12.023","article-title":"Omega-3 deficiency and neurodegeneration in the substantia nigra: involvement of increased nitric oxide production and reduced BDNF expression","volume":"1840","author":"Cardoso","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0055","doi-asserted-by":"crossref","first-page":"17692","DOI":"10.1073\/pnas.1009443107","article-title":"Glatiramer acetate triggers PI3Kdelta\/Akt and MEK\/ERK pathways to induce IL-1 receptor antagonist in human monocytes","volume":"107","author":"Carpintero","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0065","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1460-9568.2005.03985.x","article-title":"Akt is altered in an animal model of Huntington's disease and in patients","volume":"21","author":"Colin","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0070","doi-asserted-by":"crossref","DOI":"10.3791\/3200","article-title":"Lectin-based isolation and culture of mouse embryonic motoneurons","author":"Conrad","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JHD-140110","article-title":"Disease modifying potential of glatiramer acetate in Huntington's disease","volume":"3","author":"Corey-Bloom","year":"2014","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-8993(98)01258-X","article-title":"Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests","volume":"835","author":"Crawley","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0085","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1006\/nbdi.2000.0318","article-title":"Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia\/macrophages after spinal cord injury","volume":"7","author":"Dougherty","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.expneurol.2011.06.016","article-title":"IGF-1 protects against diabetic features in an in vivo model of Huntington's disease","volume":"231","author":"Duarte","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0095","doi-asserted-by":"crossref","first-page":"e16172","DOI":"10.1371\/journal.pone.0016172","article-title":"Efficacy of fumaric acid esters in the R6\/2 and YAC128 models of Huntington's disease","volume":"6","author":"Ellrichmann","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0100","doi-asserted-by":"crossref","first-page":"541259","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington's disease","volume":"2013","author":"Ellrichmann","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0105","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","article-title":"In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects","volume":"19","author":"Faideau","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/glia.22632","article-title":"Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate","volume":"62","author":"From","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0115","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1523\/JNEUROSCI.4267-13.2014","article-title":"Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination","volume":"34","author":"Fulmer","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0125","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11481-013-9436-x","article-title":"Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis","volume":"8","author":"Gentile","year":"2013","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1326-6-71","article-title":"Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction","volume":"6","author":"Giralt","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0140","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.2353\/ajpath.2010.100442","article-title":"Glatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell death","volume":"177","author":"Herrmann","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0145","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","article-title":"Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease","volume":"23","author":"Hsiao","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0150","article-title":"Dysregulation of TrkB receptors and BDNF function by amyloid-beta peptide is mediated by calpain","author":"Jeronimo-Santos","year":"2014","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0155","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1084\/jem.189.5.865","article-title":"Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?","volume":"189","author":"Kerschensteiner","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0160","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0031-1281704","article-title":"Neuroglia--living nerve glue","volume":"79","author":"Kettenmann","year":"2011","journal-title":"Fortschr. Neurol. Psychiatr."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0165","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nn1699","article-title":"BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex","volume":"9","author":"Kleim","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0170","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/1096-9861(20010219)430:4<485::AID-CNE1045>3.0.CO;2-6","article-title":"Loss of cortical and thalamic neuronal tenascin-C expression in a transgenic mouse expressing exon 1 of the human Huntington disease gene","volume":"430","author":"Kusakabe","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00401-011-0890-3","article-title":"Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination","volume":"123","author":"Lee","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0180","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nm0602-620","article-title":"CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation","volume":"8","author":"Linker","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0185","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/brain\/awq179","article-title":"Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis","volume":"133","author":"Linker","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0008-8749(82)90457-9","article-title":"Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system","volume":"73","author":"Linthicum","year":"1982","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0195","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1002\/eji.200737398","article-title":"T cell independent mechanism for copolymer-1-induced neuroprotection","volume":"37","author":"Liu","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0200","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2353\/ajpath.2006.060159","article-title":"Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study","volume":"169","author":"Maier","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0205","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2008.01.014","article-title":"Tiagabine is neuroprotective in the N171-82Q and R6\/2 mouse models of Huntington's disease","volume":"30","author":"Masuda","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0215","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/cercor\/bhp189","article-title":"BDNF val66met polymorphism influences motor system function in the human brain","volume":"20","author":"McHughen","year":"2010","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0220","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1523\/JNEUROSCI.21-16-06214.2001","article-title":"Acute neuronal apoptosis in a rat model of multiple sclerosis","volume":"21","author":"Meyer","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-5728(98)00191-X","article-title":"Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2\/Th3 immune-deviation","volume":"92","author":"Miller","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0230","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/jaut.2000.0441","article-title":"Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity","volume":"15","author":"Moalem","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0235","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression","volume":"2","author":"Mochel","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0240","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00463-2","article-title":"Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease","volume":"270","author":"Mogi","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0245","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JHD-140092","article-title":"Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease","volume":"3","author":"Nana","year":"2014","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0250","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1097\/00001756-199611250-00024","article-title":"Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease","volume":"7","author":"Narisawa-Saito","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0255","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0260","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0265","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00001756-199902250-00021","article-title":"Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra","volume":"10","author":"Parain","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0270","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","article-title":"The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington's disease mouse model","volume":"210","author":"Peng","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0275","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1098\/rstb.1999.0509","article-title":"Axon damage and repair in multiple sclerosis","volume":"354","author":"Perry","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0280","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbr.2011.01.018","article-title":"Inflammation modulates anxiety in an animal model of multiple sclerosis","volume":"220","author":"Peruga","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0285","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","article-title":"Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease","volume":"83","author":"Plotkin","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0290","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","article-title":"Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression","volume":"19","author":"Pouladi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0295","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jb\/mvr066","article-title":"AKT down-regulates insulin-like growth factor-1 receptor as a negative feedback","volume":"150","author":"Qin","year":"2011","journal-title":"J. Biochem."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0300","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/mus.23843","article-title":"Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study","volume":"48","author":"Querol","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0305","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease","volume":"82","author":"Reynolds","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0310","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1651-2227.1999.tb14372.x","article-title":"Human growth disorders: molecular genetics of the growth hormone-insulin-like growth factor I axis","volume":"88","author":"Rotwein","year":"1999","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0315","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.autrev.2007.02.003","article-title":"Glatiramer acetate: mechanisms of action in multiple sclerosis","volume":"6","author":"Schrempf","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0320","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(82)90344-4","article-title":"Huntington's disease: changes in striatal proteins reflect astrocytic gliosis","volume":"245","author":"Selkoe","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0325","first-page":"575","article-title":"Molecular biology of neurotrophic factors","volume":"4","author":"Sendtner","year":"1995","journal-title":"Baillieres Clin. Neurol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0330","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington's disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0335","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/brain\/awf015","article-title":"BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?","volume":"125","author":"Stadelmann","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0340","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1196\/annals.1309.055","article-title":"Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies","volume":"1029","author":"Teitelbaum","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0345","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice","volume":"17","author":"Tong","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0350","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/ncomms2536","article-title":"Haematopoietic cells produce BDNF and regulate appetite upon migration to the hypothalamus","volume":"4","author":"Urabe","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0355","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2007.07.029","article-title":"Increased metabolism in the R6\/2 mouse model of Huntington's disease","volume":"29","author":"van der Burg","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0360","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0365","first-page":"R992","article-title":"Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus increases energy expenditure by elevating metabolic rate","volume":"293","author":"Wang","year":"2007","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0370","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.nurt.2007.08.002","article-title":"Mechanism of action of glatiramer acetate in treatment of multiple sclerosis","volume":"4","author":"Weber","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0375","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fphar.2012.00120","article-title":"Astrocytes as a source for extracellular matrix molecules and cytokines","volume":"3","author":"Wiese","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0380","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0385","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-5728(93)90162-R","article-title":"Enhancement of histamine-induced vascular leakage by pertussis toxin in SJL\/J mice but not BALB\/c mice","volume":"45","author":"Yong","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0390","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jns.2012.06.004","article-title":"Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders","volume":"322","author":"Zadori","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2016.08.012_bb0395","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00115-001-1257-0","article-title":"Treatment of multiple sclerosis with glatiramer acetate. Current aspects of mechanisms of action, pharmacokinetics, adverse effect profile and clinical studies","volume":"73","author":"Ziemssen","year":"2002","journal-title":"Nervenarzt"},{"key":"10.1016\/j.expneurol.2016.08.012_bb0400","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616302515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616302515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T19:35:24Z","timestamp":1601062524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488616302515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":79,"alternative-id":["S0014488616302515"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.08.012","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6\/2 and YAC128 mouse models of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}